Followers | 901 |
Posts | 148899 |
Boards Moderated | 0 |
Alias Born | 08/13/2010 |
Wednesday, December 16, 2020 10:05:18 AM
https://fool.com/investing/2020/12/16/why-astrazenecas-and-sanofis-bad-news-could-be-gre/
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent SNY News
- Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). • Edgar (US Regulatory) • 02/23/2024 07:02:56 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/23/2024 04:15:26 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 05:09:49 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:57:49 PM
- Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE) • GlobeNewswire Inc. • 01/25/2024 07:29:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/23/2024 12:23:49 PM
- Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update • Dow Jones News • 01/23/2024 11:05:00 AM
- Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More • IH Market News • 01/23/2024 10:40:18 AM
- Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B • PR Newswire (US) • 01/23/2024 06:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/17/2024 06:49:56 PM
- Sanofi Names Brian Foard Head of Specialty-Care Unit • Dow Jones News • 01/09/2024 07:14:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 04:18:58 PM
- Sanofi Ends Drug Program After Late-Stage Trial in Lung Cancer Fails • Dow Jones News • 12/21/2023 07:25:00 AM
- Innate Pharma Shares Rise after Sanofi Exercises Licensing Option • Dow Jones News • 12/19/2023 12:28:00 PM
- Hasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and More • IH Market News • 12/12/2023 10:50:47 AM
- Sanofi Terminates Agreement with Maze Therapeutics Following FTC Opposition • Dow Jones News • 12/11/2023 10:18:00 PM
- Sanofi Sees Improvement in Trial Results of Cancer Drug Sarclisa • Dow Jones News • 12/11/2023 06:50:00 AM
- Sanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage Trial • Dow Jones News • 12/07/2023 07:34:00 AM
- Sanofi Sees Annual Sales From New Pharma Assets Above $10.8 Billion by 2030 • Dow Jones News • 12/07/2023 07:20:00 AM
- Trending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage Trials • Dow Jones News • 12/06/2023 01:20:00 PM
- Merck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage Trials • Dow Jones News • 12/06/2023 10:14:00 AM
- Teva Closes Collaboration Deal With Sanofi on IBD Treatment • Dow Jones News • 11/30/2023 02:23:00 PM
- Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment • Business Wire • 11/30/2023 01:30:00 PM
- Trending: Sanofi's Notus Trial Meets Primary Endpoint • Dow Jones News • 11/27/2023 03:31:00 PM
- Sanofi Says Notus Phase 3 Trial of Dupixent Met Primary Endpoint • Dow Jones News • 11/27/2023 07:40:00 AM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM